Back to search

United Kingdom· GB-APID-20139911000001104

Tolazoline 20mg/2ml solution for injection ampoules

A tolazoline product containing tolazoline, registered in United Kingdom by Special Order.

ATC C04AB02

Checked against NHS dm+d (United Kingdom) on

Informational only — not a medical device.

SOURCE REGISTER · GBNHS dm+d (United Kingdom)normalisedTolazoline 20mg/2ml solution for inje…ATCC04AB02REGISTER NO.GB-APID-2013991100000…PACKS LISTED0CHECKEDSeptember 13, 2026

The record

At a glance

NHS dm+d (United Kingdom)
Active substance
Tolazoline
Manufacturer
Special Order
Country
United Kingdom (GB)
ATC code
C04AB02
ATC class
Tolazoline
Defined daily dose
75 mg, O
Reimbursed
Not published by this register
Source register
NHS dm+d (United Kingdom)
Last checked
September 13, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

20 interactions on record for tolazoline.

Graded by severity as the source publishes them — 20 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Tolazoline · interactions on record

20 records

  • 20 moderate

Most severe, free to view

  • DapagliflozinA10BK01moderate
  • CanagliflozinA10BK02moderate
  • EmpagliflozinA10BK03moderate
  • ErtugliflozinA10BK04moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/1424137c-363a-4e9a-8bb9-2d2cf9dd248e
GET /v1/drugs/1424137c-363a-4e9a-8bb9-2d2cf9dd248e?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "apid": "20139911000001104",
  "desc": "Tolazoline 20mg/2ml solution for injection ampoules (Special Order)",
  "form": "Solution for injection",
  "vpid": "20139611000001105",
  "source": "dmd",
  "vtm_id": "777797003",
  "strength": "10 mg",
  "substance": "Tolazoline",
  "ingredient": "Tolazoline hydrochloride",
  "supplier_code": "8286711000001104"
}

See everything about tolazoline.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.